Theriva Biologics, Inc. Shareholders' Equity
Theriva Biologics, Inc. (TOVX) had Shareholders' Equity of $56.39 million as of 2022-09-30, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-03-30
- 2022-09-30: Stockholders' Equity Attributable to Parent $56.39M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $62.22M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $65.41M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $73.33M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-09-30 | $56.39M 10-K · filed 2023-03-30 | |
| 2022-06-30 | $62.22M 10-K · filed 2023-03-30 | |
| 2021-12-31 | $65.41M 10-K · filed 2022-03-16 | |
| 2021-09-30 | $73.33M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $76.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $79.60M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | -$4.77M 10-K · filed 2022-03-16 | |
| 2020-09-30 | -$6.05M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$3.97M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$1.12M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.82M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $4.93M 10-K · filed 2020-02-20 | |
| 2019-06-30 | $10.02M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $13.52M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $17.07M 10-K · filed 2020-02-20 | |
| 2018-09-30 | -$3.73M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$6.49M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$3.19M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$1.50M 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$4.79M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $4.83M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $2.57M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $3.85M 10-K · filed 2018-02-22 | |
| 2016-09-30 | -$4.48M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $2.29M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $6.26M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $16.05M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $25.87M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$13.66M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$1.63M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $9.56M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $3.76M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $8.06M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $11.76M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $15.23M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $6.37M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $9.40M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $11.49M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $13.03M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $5.41M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $6.85M 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $7.91M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $7.06M 10-K · filed 2013-04-16 | |
| 2011-09-30 | $8.44M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $9.12M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $3.58M 10-K · filed 2013-04-16 | $3.58M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $3.54M 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |